Phenotypic and functional characterisation of monocytic microparticles (mMP) derived from U937 and THP-1 cell lines by Ariffin, Nur Azrah Fazera Mohd
  
PHENOTYPIC AND FUNCTIONAL 
CHARACTERISATION OF MONOCYTIC 
MICROPARTICLES (mMP) DERIVED FROM U937 
AND THP-1 CELL LINES 
 
 
 
 
NUR AZRAH FAZERA BINTI MOHD ARIFFIN 
 
 
 
 
 
UNIVERSITI SAINS MALAYSIA 
2018 
  
PHENOTYPIC AND FUNCTIONAL 
CHARACTERISATION OF MONOCYTIC 
MICROPARTICLES (mMP) DERIVED FROM U937 
AND THP-1 CELL LINES 
 
 
by 
 
 
NUR AZRAH FAZERA BINTI MOHD ARIFFIN 
 
 
Thesis submitted in fulfillment of the requirement 
 for the degree of  
Master of Science 
 
July 2018 
  
 
 
ii 
 
ACKNOWLEDGEMENTS  
 
First and foremost, all praises and thanks to Allah S.W.T, the Most Beneficent and the 
Most Merciful for giving me strength and ease my journey to complete my MSc. study.  
 
I would like to forward my deepest gratitude to Dr. Maryam Azlan as my main supervisor 
who patiently guided me throughout my research period. I also want to express my 
warmest gratitude to my co-supervisors, Dr. Zefarina Zulkafli and Associate Professor Dr. 
Rapeah Supian who assisted me to expand some parameters in my study. They are truly 
my backbones to accomplish my study in Master of Science. 
 
Throughout 3 years I have been in USM, I was blessed with friendly and helpful hands 
from laboratory officers and technologist from School of Health Sciences, Hematology 
and Immunology Laboratory (School of Medical Sciences), Craniofacial Laboratory 
(School of Dental Sciences) and Institute for Research in Molecular Medicine 
(INFORMM). Mrs. Rosmaizati, Mr. Jamarudin and Mr. Khairul among the noticeable 
people behind my every laboratory works. Special thanks to my colleagues; Azira, 
Zulaiha, Munirah, Aina, Huda, Raihanah, Syazana, Fadhilah, Aminah, Hazirah, Fakqrul, 
Fatin and Farieha who coloured my every up and down moments. I also owe a great debt 
of gratitude to Dr Hermizi Hapidin and Tarmizi for revising my thesis. 
 
  
 
 
iii 
 
My heartfelt thanks go to all my family members for their continuous moral support and 
endless love. May our Lord repay all your kind prayers and grant us a continuous blessing.  
 
Last but not least, I would like to acknowledge the financial aids from Graduate Research 
Assistant, MyBrain 15 and USM Graduate Assistant Scheme Research. This research was 
funded by Fundamental Research Grant Scheme (FRGS/203/PPSK/6171170) from 
Ministry of Higher Education (MOHE). 
 
Thank you. 
 
 
  
  
 
 
iv 
 
TABLE OF CONTENTS 
 
Acknowledgements ii 
Table of Contents iv 
List of Figures ix 
List of Tables xi 
List of Symbols and Abbreviations xii 
Abstrak xvi 
Abstract xviii 
CHAPTER 1 INTRODUCTION 1 
1.1 Background of the study 1 
1.2 Rationale of the study 3 
1.3 Objectives of the study 4 
1.3.1 General objective 4 
1.3.2 Specific objectives 4 
CHAPTER 2 LITERATURE REVIEW 5 
2.1 Monocytes 5 
2.1.1 Origin, function and classification 5 
2.1.2 Monocytic cell lines 8 
2.1.2 (a) THP-1 and U937 9 
2.2 Microparticles 10 
2.2.1 Origin and structure of microparticles 14 
  
 
 
v 
 
2.2.2 Formation and function of microparticles 16 
2.2.3 Leukocytes-derived microparticles (LMP) 17 
2.2.4 Isolation of microparticles 19 
2.2.5 Detection of microparticles 21 
2.2.5 (a) Flow cytometry analysis 23 
2.3 Monocytic Microparticles 25 
2.3.1 Monocytic microparticles surface markers 25 
2.3.2 Mechanism of monocytic microparticles 28 
2.3.3 Monocytic microparticles during inflammation 30 
2.3.4 Coagulation potential of monocytic microparticles 31 
2.3.4 (a) Prothrombin time assay 33 
2.3.5 Monocytic microparticles in disease setting 35 
CHAPTER 3 MATERIALS AND METHODS 37 
3.1 Experimental design 37 
3.1 Laboratory materials 38 
3.1.1 List of chemicals, reagents, antibodies, softwares and laboratory                   38 
         instruments  
3.1.2 Preparation of buffer and reagent solutions 41 
3.1.2 (a) Preparation of 1X phosphate buffer saline (PBS) 41 
3.1.2 (b) 70% ethanol preparation 41 
3.1.2 (c) Dilution of recombinant human tumor necrosis factor-α 41                   
         (TNF-α)  
  
 
 
vi 
 
3.1.2 (d) Dilution of lipopolysaccharide (LPS) 41 
3.1.2 (e) Fluorescence-activated cell sorting (FACS) buffer preparation 42 
3.1.2 (f) Wash buffer (PBS-T20 buffer) for ELISA 42 
3.1.2 (g) Stop solution for ELISA 42 
3.2 Methods 42 
3.2.1 Preparation of monocytic cell line culture 42 
3.2.1 (a) Preparation of fetal bovine sera 43 
3.2.1 (b) Preparation of complete Roswell-Park Memorial Institute               43 
               (RPMI)-1640 medium.  
3.2.1 (c) Preparation of cryopreservation medium 43 
3.2.2 Maintenance of monocytic cells 43 
3.2.2 (a) Thawing of cryopreserved U937 and THP-1 monocytic cells 43 
3.2.2 (b) Culture of U937 and THP-1 monocytic cells 44 
3.2.2 (c) Subculture of U937 and THP-1 monocytic cells 44 
3.2.2 (d) Cryopreservation of U937 and THP-1 monocytic cells 44 
3.2.2 (e) Cell viability assessment 45 
3.2.3 Monocytic microparticles isolation 45 
3.2.4 Monocytic microparticles and cell staining for flow cytometry analysis 46 
3.2.5 Flow cytometry analysis 48 
3.2.6 Detection of proinflammatory cytokines 49 
3.2.6 (a) Samples preparation 49 
3.2.6 (b) Enzyme-linked immunosorbent assay (ELISA) 52 
  
 
 
vii 
 
3.2.7 Clot time analysis 52 
3.2.8 Endotoxin detection in cell and monocytic microparticle preparation 53 
3.2.9 Statistical analysis 53 
CHAPTER 4 RESULTS 54 
4.1 Detection of monocyte and monocytic microparticle surface markers by 54  
      flow cytometry  
4.1.1 Surface marker expressions on U937 cells and U937 monocytic                    60 
         microparticles  
4.1.1 (a) U937 cell surface marker expressions 60 
4.1.1 (b) U937 monocytic microparticle surface marker expressions 62 
4.1.2 Surface marker expressions on THP-1 cells and THP-1 monocytic 65 
         microparticles  
4.1.2 (a) THP-1 cell surface marker expressions 65 
4.1.2 (b) THP-1 monocytic microparticle surface marker expressions 67 
4.1.3 Comparison of surface marker expression between monocytes and 70                 
         monocytic microparticles  
4.2 Detection of proinflammatory cytokines; Interleukin-1β (IL-1β) and Tumor           74 
      Necrosis Factor-α (TNF-α)  
4.2.1 IL-1β level in supernatant samples 75 
4.2.2 TNF-α level in supernatant samples 77 
4.3 Analysis of clot time measurement of monocytic microparticles 79 
CHAPTER 5 DISCUSSION 81 
  
 
 
viii 
 
5.1 Production of monocytic microparticles from U937 and THP-1 gave rise to            81 
     different phenotypes 81 
5.2 Proinflammatory cytokine secretion by monocytic microparticles 87 
5.3 Procoagulant property of mMP 92 
5.4 Limitation of the study 94 
5.5 Future studies 96 
CHAPTER 6 CONCLUSION 97 
REFERENCES 99 
APPENDICES  
Appendix A: Certificate of analysis U937 cells  
Appendix B: Certificate of analysis THP-1 cells  
Appendix C: Cell Morphology  
Appendix D: Optimisation of LPS and TNF-α concentration to secrete cytokines  
Appendix E: Oral presentation  
Appendix F: Publication (Review article)  
  
 
 
ix 
 
LIST OF FIGURES 
Page 
Figure 2.1 Origin of human blood cells. 6 
Figure 2.2  Structure and cellular composition of microparticle. 15 
Figure 2.3  The generation mMP through various stimuli in vitro and their 
potential functions. 
29 
Figure 2.4  Blood coagulation cascade that comprise of three main 
pathways; intrinsic, extrinsic and common pathway. 
34 
Figure 3.1  Flow chart of the study. 37 
Figure 4.1  Detection of monocytes and monocytic microparticle 
populations. 
55 
Figure 4.2  The gating strategy of mMP populations based on size 
fluorescent beads. 
56 
Figure 4.3  The quantification of mMP using TruCount beads. 59 
Figure 4.4 The expression of selected cell surface markers on U937 cells. 61 
Figure 4.5 The expression of monocytic surface markers in combination 
with Annexin-V on U937 mMP. 
64 
Figure 4.6 The expression of selected cell surface markers on THP-1 cells. 66 
Figure 4.7  The expression of monocytic surface markers in combination 
with Annexin-V on THP-1 mMP. 
69 
Figure 4.8  Surface antigen expression of monocytes (U937 and THP-1) 
and their derived monocytic microparticles. 
73 
  
 
 
x 
 
Figure 4.9  Interleukin-1β (IL-1β) secretion level. 76 
Figure 4.10 Tumor necrosis factor-α (TNF-α) secretion level. 78 
Figure 4.11 The prothrombin time of LPS-stimulated monocytic 
microparticles. 
80 
 
 
  
 
 
xi 
 
LIST OF TABLES 
Page 
Table 2.1  Characteristics of extracellular vesicles. 11 
Table 2.2  List of antigens that are expressed on microparticles derived 
from erythrocytes, platelets, neutrophils, monocytes, 
lymphocytes and endothelial cells. 
13 
Table 2.3  List of microparticle detection methods. 22 
Table 2.4  Membrane and cytoplasmic protein profiles of monocytic 
microparticles. 
27 
Table 3.1  List of chemicals and reagents. 38 
Table 3.2  List of antibodies. 39 
Table 3.3  List of softwares. 40 
Table 3.4  List of laboratory instruments. 40 
Table 3.5  Supernatant samples for ELISA which were isolated from 3 
different sources. 
51 
 
  
  
 
 
xii 
 
LIST OF SYMBOLS AND ABBREVIATIONS  
 
~ Approximately 
% Percentage  
ºC Degree Celsius 
µg Microgram  
µL Microlitre 
µM Micromolar 
APC Antigen presenting cells 
aPTT Activated partial thromboplastin time  
ATCC American Type Culture Collection 
BSA Bovine serum albumin 
CD Cluster of differentiation 
CMP Common myeloid progenitors 
DMSO Dimethyl sulfoxide 
DNA Deoxyribonucleic acid 
CO2 Carbon dioxide 
ELISA Enzyme-linked immunosorbent assay 
FACS Fluorescence-activated cell sorting 
FBS Fetal bovine serum 
FITC Fluorescein isothiocyanate 
FSC Forward scatter 
  
 
 
xiii 
 
g Gram 
GMP Granulocyte-macrophage progenitors  
H2SO4 Hydrosulfuric acid 
HSC Haematopoietic stem cells 
HUVEC Human umbilical vein endothelial cells 
IFN Interferon 
Ig Immunoglobulin 
IL-1β Interleukin-1 beta 
L Litre  
LMP Leukocyte microparticles 
LPS Lipopolysaccharides 
mAb Monoclonal antibodies 
MDP Macrophage and dendritic cell precursors 
MFI Mean fluorescent intensity 
mg Milligram 
mL Millilitre  
mm Millimetre  
mMP Monocytic microparticles 
MP Microparticles 
ng Nanogram 
nm Nanomolar 
NMP Neutrophil microparticles 
  
 
 
xiv 
 
NTA Nanoparticle tracking analysis 
PAMP Pathogen-associated molecular patterns 
PBMC Peripheral blood mononuclear cells 
PBS Phosphate buffer saline 
PCR Polymerase chain reaction 
PE Phycoerythrin 
PS Phosphatidylserine  
PT Prothrombin time 
PSG Penicillin, streptomycin with glutamine 
PSGL-1 P-selectin glycoprotein ligand-1 
PRR Pattern recognition receptors 
ROS Reactive oxygen species 
rpm Revolutions per minute 
RPMI-1640 Rosewell-Park Memorial Institute-1640 
SEM Standard error of the mean 
SSC Side scatter 
TF Tissue factor 
TF+MP Tissue factor-bearing microparticles 
TFPI Tissue factor pathway inhibitor 
THP-1 mMP THP-1 monocytic microparticles 
TLR Toll-like receptor 
TM Thrombomodulins 
  
 
 
xv 
 
TNF-α Tumor necrosis factor alpha 
U937 mMP U937 monocytic microparticles 
VCAM Vascular cell adhesions molecules 
VGEF Vascular endothelial growth factors 
 
 
  
 
 
xvi 
 
PENCIRIAN FENOTIP DAN FUNGSI MONOSITIK MIKROPARTIKEL (mMP) 
YANG DIREMBES OLEH SEL TERBITAN U937 DAN THP-1 
 
ABSTRAK 
 
               Monositik mikropartikel (mMP) ialah partikel membran berdiameter 0.1-1.0 µm 
yang berasal daripada monosit manusia. Ianya dirembes semasa keadaan fisiologi badan 
yang normal seperti pengaktifan sel-sel dan apoptosis atau dalam keadaan berpenyakit.  
Monositik MP berperanan penting dalam keradangan, fungsi sel endotelium dan 
pembekuan darah, namun mekanisme mMP dalam situasi tersebut belum diperincikan. 
Monositik MP boleh dikenalpasti melalui ekspresi-ekspresi antigen sel induknya iaitu 
CD14 dan fosfatidilserin pada permukaan mMP menggunakan sitometri aliran. Dalam 
kajian ini, kami menggunakan sel-sel terbitan monositik iaitu U937 dan THP-1 untuk 
mengkaji rembesan mMP dengan kaedah ‘in vitro’. Sebanyak 1x106 sel/mL dirangsang 
oleh 1 μg/mL ‘lipopolysaccharide’ (LPS) atau 10 ng/mL ‘recombinant human tumor 
necrosis factor-α’ (TNF-α) selama 18 jam dalam 5% CO2 inkubator pada suhu 37°C. 
Kemudian, mMP diasingkan melalui tiga fasa pengemparan berbeza: (i) 500 xg untuk 
mengeluarkan pelet sel, (ii) 1,500 xg untuk membersihkan serpihan sel dan (iii) 20,000 xg 
ultra-pengemparan untuk mengumpul mendapan mMP. Objektif kajian ini menumpukan 
tinjauan awal tentang ekspresi antigen pada permukaan mMP, rembesan sitokin-sitokin 
yang bersifat pro-keradangan dan potensi mMP dalam pembekuan darah. Berdasarkan 
teori, populasi mMP adalah populasi yang mengekspreskan Annexin-V bersama CD14 
  
 
 
xvii 
 
iaitu penanda sel induknya. Hasil kajian kami mendapati mMP terbitan U937 dan THP-1 
tidak semestinya mempamerkan ekspresi yang sama seperti sel induknya. Seterusnya, 
kami mengenalpasti keupayaan mMP sendiri dalam merembes sitokin-sitokin pro-
keradangan iaitu ‘interleukin-1β’ (IL-1β) dan TNF-α serta menguji mMP tersebut sama 
ada mampu meningkatkan rembesan sitokin-sitokin tersebut daripada sel induknya, U937 
dan THP-1. Hasil kajian menunjukkan mMP mampu merembes IL-1β tetapi gagal 
merangsang perembesan IL-1β yang terhasil daripada pengkulturan bersama sel U937 dan 
THP-1. Manakala, TNF-α pula didapati mampu dirembes daripada mMP yang terhasil 
daripada rangsangan TNF-α pada sel U937. Monositik MP tersebut juga mampu 
merangsang perembesan sel induknya iaitu U937, secara pengkulturan bersama iaitu 
sebanyak hampir 400 pg/mL sitokin TNF-α. Selain itu, mMP berpotensi sebagai pro-
koagulasi sebagaimana dipamerkan oleh penanda CD142 pada kedua-dua mMP serta, 
ujikaji masa ‘prothrombin’ menunjukkan semakin banyak mMP, semakin singkat masa 
yang diperlukan untuk koagulasi berlaku. Sebagai kesimpulan, mMP terbitan daripada 
pelbagai jenis sel-sel monosit mempunyai ciri-ciri fenotip yang berbeza. Oleh itu, 
penyelidikan terperinci pada masa hadapan perlu dijalankan untuk mengukuhkan lagi 
pencirian mMP yang terhasil daripada darah manusia serta kaitan mMP dengan implikasi 
klinikal terutama dalam bidang penyakit berkaitan keradangan.   
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PHENOTYPIC AND FUNCTIONAL CHARACTERISATION OF MONOCYTIC 
MICROPARTICLES (mMP) DERIVED FROM U937 AND THP-1 CELL LINES 
 
ABSTRACT 
 
 Monocytic microparticles (mMP) are 0.1-1.0 µm membrane particle, shed from 
human monocytes under physiological condition such as cellular activation and apoptosis 
or during certain pathological conditions. It has been reported in the literatures that mMP 
play important roles in inflammation, endothelial cell function and blood coagulation, 
however, the mechanism involved is still unclear. Monocytic MP can be characterised by 
the expression of their parental cell antigen, CD14 along with phosphatidylserine (PS) on 
mMP surface which can be detected by flow cytometry. This study was conducted using 
U937 and THP-1 monocytic cell lines. To induce mMP production in vitro, 1 x 106 cells 
were stimulated with 1 µg/mL lipopolysaccharide (LPS) or 10 ng/mL recombinant human 
tumor necrosis factor-α (TNF-α) for 18 hours in 5% CO2 humidified incubator at 37°C.  
Then, mMP were isolated through three differential centrifugations: (i) 500 xg to remove 
cell pellet, (ii) 1,500 xg to remove cell debris and (iii) 20,000 xg ultra-centrifugation to 
pellet mMP. This study was aimed to identify mMP surface marker expression by flow 
cytometry, measure mMP-induced proinflammatory cytokine secretions and assess 
coagulation potential of mMP. Theoretically, mMP populations are defined as positive for 
Annexin-V in combination with monocytic marker, CD14. Our finding has shown that 
U937 mMP and THP-1 mMP does not necessarily follow the same surface antigen 
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expression as their parent cells. We then investigated the ability of mMP to secrete 
proinflammatory cytokines; TNF-α and interleukin 1 beta (IL-1β) and also tested mMP 
potential to modulate cytokine secretions in U937 and THP-1 cells. We found that IL-1β 
was secreted from both mMP but was down regulated when co-cultured with U937 and 
THP-1 cells. TNF-α was secreted from all TNF-α-stimulated samples and only mMP-
derived U937 upregulated TNF-α secretion almost up to 400 pg/mL from TNF-α- 
stimulated U937 cells. Besides that, mMP may have a procoagulant potential as shown by 
high expression of CD142 on both mMP surface and shorter prothrombin time (PT) over 
an increasing number of mMP. In conclusion, different monocytic cells may give rise to 
different properties of mMP. Further study should be carried out to establish a detail 
characterisation of mMP isolated from human blood and discover the clinical implications 
of mMP especially in inflammation-related diseases. 
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CHAPTER 1 
INTRODUCTION 
 
1.1  Background of the study 
Monocytes are a type of white blood cell that participate in the immune responses. They 
originate from the bone marrow and circulate in the blood within 1–2 days. Upon host 
exposure to foreign pathogens (e.g., virus, bacteria, fungi), the first line defence system 
known as innate immune response will be activated to prevent these pathogens from 
entering the host. However, if the innate immune system is incapable of removing the 
pathogens, infection might occur and may lead to inflammation (Peter et al., 2012).   
During infection, monocytes migrate to the infected tissue and differentiate into 
macrophages, followed by phagocytosis of pathogens. Immune cells are also recruited 
along with chemoattractants followed by secretion of inflammatory cytokines (Abbas et 
al., 2011; Lydyard et al., 2011; Peter et al., 2012). Concurrently, microbial products 
released around the inflamed sites may trigger monocytes to release small membrane 
vesicles known as monocytic microparticles (mMP)  (Baron et al., 2012). 
 
Monocytic microparticles are microvesicles ranging from 0.1 to 1.0 µm in diameter and 
are secreted from the plasma membrane of monocytes in response to cellular activation 
and apoptosis (Wu et al., 2013). Due to high phosphatidylserine (PS) expression on 
microparticles (MP) surface membrane arise from the loss of cell plasma membrane 
symmetry during MP formation, MP are often characterised as being Annexin V positive, 
which binds to PS (Burnier et al., 2009). In addition, MP also express cell surface antigens 
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which highlight their origin, for example, CD14 for monocytes, CD144 for endothelial 
cells and CD162 for activated T-lymphocytes. Similar to other MP, theoretically mMP 
can be characterised by the expression of their original cell surface marker, CD14 and PS 
on their surface membranes (van Ierssel et al., 2010). However, mMP derived from 
unstimulated monocytes was reported to possess undetectable  CD14 expression  
(Crompot et al., 2015).  
 
Currently, research on mMP has gained interest as they have been shown to  participate 
in coagulation (Wen et al., 2014), inflammation (He et al., 2017) and cell-to–cell 
communication as well as being an indicator for certain pathological conditions (Walsh et 
al., 2017). Monocytic MP are abundant in many pathological settings and their number is 
reported to increase in infection (Mack et al., 2000; Ling et al., 2011), endothelial cells 
function (Wang et al., 2011) and immune-mediated diseases (Distler et al., 2005a; 
Takeshita et al., 2014). In a healthy individual, circulating mMP exist more likely due to 
apoptosis process from aging (Zubairova et al., 2015). To date, the role of mMP in the 
circulation during certain pathological conditions may either assist in progressing or 
limiting the diseases, or simply function as biomarkers (Halim et al., 2016). Even though 
many studies of MP have been reported, the exact function and importance of mMP in 
physiological conditions is not clear. Hence, a consistent characterisation and detection 
criteria of mMP is required.  
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1.2  Rationale of the study  
Research interest in MP has increased over the past decades. To date, many researches 
have focused on MP derived from endothelial cells and platelets as well as their role in 
vascular biology (Hoyer et al., 2012). In this study, U937 and THP-1 monocytic cell lines 
were used as monocyte models due to their ability to mimic monocytes. These monocytic 
cell lines are easier to be cultured in a large quantity compared to primary monocytes 
isolated from human blood. It has been reported previously that mMP derived from LPS-
stimulated THP-1 play a role in inflammation (Wen et al., 2014), thrombin and fibrin 
generation, coagulation (Aleman et al., 2011) and endothelial cell function (Wang et al., 
2011). To date, information on mMP characterisation derived from U937 and THP-1 is 
still lacking while the role of mMP derived from primary monocytes is also unclear. 
Monocytic MP have been shown to secrete pro-inflammatory cytokines such as TNF-, 
IL-6 and IL-8 (Distler et al., 2005b; Cerri et al., 2006; Wen et al., 2014). A previous study 
has shown that interleukin-1β, a proinflammatory cytokine secreted from LPS-stimulated 
mMP, was able to aid endothelial cell activation and thus amplify inflammation (Wang et 
al., 2011). However, they did not assess the ability of mMP in upregulating monocytes to 
increase the secretion of proinflammatory cytokine in an autocrine manner as suggested 
by other literatures (Bardelli et al., 2012; Schildberger et al., 2013). 
 
Our study focused on characterising mMP phenotypes derived from LPS- and TNF-α-
stimulated U937 and THP-1 monocytic cells through differential centrifugation steps. To 
assess mMP function, we tested the coagulation potential of mMP and cytokine secretion 
through prothrombin time assay and enzyme-linked immunosorbent assay (ELISA) 
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respectively. We hypothesised that mMP derived from LPS- and TNF-α-stimulated U937 
and THP-1 cells may differentially modulate cell surface expression, proinflammatory 
cytokine secretion, and coagulation properties, given that different types of monocytic cell 
lines have unique phenotype and function. 
 
1.3  Objectives of the study 
1.3.1  General objective 
To characterise surface phenotypes and functions of monocytic microparticles derived 
from U937 and THP-1 monocytic cells following lipopolysaccharide (LPS) and TNF-α 
stimulations. 
  
1.3.2  Specific objectives 
1) To determine cell surface antigen of monocytic microparticles derived from stimulated 
U937 and THP-1.  
2) To measure the level of proinflammatory cytokines (interleukin-1β [IL-1β] and TNF-
α) in mMP culture and mMP co-culture with U937 and THP-1.  
3) To assess coagulation property of mMP derived from U937 and THP-1.  
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CHAPTER 2  
LITERATURE REVIEW 
 
2.1  Monocytes  
2.1.1  Origin, function and classification 
Monocytes are part of the immune system that comprise 5% to 10% of total leukocytes. 
They originate from haematopoietic stem cells (HSC) in the bone marrow before 
undergoing specific differential stages, for example, common macrophage and dendritic 
cell precursors (MDP), common myeloid progenitors (CMP), or granulocyte-macrophage 
progenitors (GMP) (Figure 2.1). After being produced in the bone marrow, inactive 
monocytes circulate in the blood for 1–2 days before differentiating into either a mature 
form or undergoing apoptosis. Monocytes can be characterised by their agranular feature 
with size 15 to 20 µm in diameter, kidney-shaped nucleus, and cytoplasmic vesicles 
(Akashi et al., 2000; Fogg et al., 2006; Hettinger et al., 2013).  
 
Monocytes play an important role as an innate effector by initiating inflammatory 
response towards microbes by phagocytosing pathogens, producing reactive oxygen 
species (ROS), and secreting inflammatory cytokines. In pathological conditions, 
monocytes contribute to atherogenesis, angiogenesis, and myeloperoxidase production 
(Serbina et al., 2008; Avraham-Davidi et al., 2013). In the tissues, monocytes are 
commonly known as macrophages. The ability of macrophage to phagocytose foreign 
invaders are important during infection. Macrophages are attracted to infection sites  
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Figure 2.1 Origin of human blood cells. Monocytes are a group of myoblasts which originated from myeloid progenitor.  
Monocytes, basophils, neutrophils, and eosinophils are known as leukocytes, which play a major role in the human defence  
system. Activated monocytes differentiate into macrophages which function as antigen-presenting cells (APC). Adapted from  
Shaikh and Bhartiya (2012).
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via chemotaxis, adhere to pathogens, ingest them and subsequently destroy the pathogens 
(Lydyard et al., 2011). This mechanism needs an interaction between the surface receptor 
(pattern recognition receptors, PRR) of monocytes/macrophages and the pathogen-
associated molecular patterns (PAMP) of microbes. Examples of PAMP that can be 
recognised by monocytes are bacterial lipopolysaccharides (endotoxin), terminal mannose 
residues on bacterial glycoproteins, and CpG (cytosine-guanine) nucleotide in bacterial 
DNA. The PRR such as the toll-like receptor, Fc receptor, and adhesion receptor, allow 
monocytes/macrophages to detect and recognise various pathogens (e.g., bacteria, 
parasites, and worms) and subsequently releasing inflammatory mediators to trigger the 
adaptive immune responses (Peter et al., 2012).  
 
Human blood monocytes are classified according to their surface expression of CD16 and 
CD14 antigens. Monocyte subsets can be subdivided into classical monocytes (CD14++ 
CD16-) that comprise 90% of total monocytes, 10% intermediate monocytes (CD14++ 
CD16+) and relatively low amount of non-classical monocytes (CD14dim CD16++), as 
reported by the Nomenclature Committee of the International Union of Immunological 
Societies (Italiani and Boraschi, 2014; Angelovich et al., 2015). Nevertheless, the 
physiological role of these monocyte subsets in vivo was not fully elucidated. Different 
monocyte subsets have different roles during homeostasis, immune defense, 
inflammation, and tissue repair, in terms of their capacity to become activated and secrete 
inflammatory cytokines in response to different stimuli, antigen processing and 
presentation (Italiani and Boraschi, 2014). 
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2.1.2  Monocytic cell lines 
Cell lines are preferred by most researchers because of their ability to grow to a large 
number within a short period of time compared to primary cells. Monocytic cell lines are 
a group of cell population that phenotypically and genetically resemble human primary 
monocytes (Daigneault et al., 2010). Monocytic cell lines are easily accessible compared 
to blood monocytes without the requirement of isolation steps from blood. Furthermore, 
inaccurate prediction of the actual role of monocytes arising from interference with other 
blood components can be avoided due to the homogeneity of the cell lines (Shet, 2008). 
 
There are numerous monocytic cells namely U937, THP-1, HL-60, ML-2, and 
Mononomac-1. They have an extended life span by continuous passage within a long time 
(Chanput et al., 2015) and are commonly studied for cell proliferation and differentiation 
into macrophages by using different stimuli such as phorbol-12-myristate-13-acetate 
(PMA), 1,25-dihydroxyvitamin D3 (VD3), ionomycin, and 12-O-tetradecanoylphorbol-
13-acetate (TPA) (Yazdanparast et al., 2006; Daigneault et al., 2010; Posada et al., 2015). 
In addition, the use of cell lines enables the study of macrophage function because primary 
macrophages are difficult to isolate and grown ex vivo. Although in vitro differentiation 
of macrophage may not resemble the actual in vivo condition, the use of cell lines are still 
preferred due to the availability and easy to grow (Daigneault et al., 2010). 
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2.1.2 (a)  THP-1 and U937 
THP-1 and U937 are single-rounded monocytic cells that exist in a suspension during 
early culture state. THP-1 is a leukaemic cell line derived from of an acute monocytic 
leukaemic patient in 1980 (Tsuchiya et al., 1980). THP-1 cells are widely used to study 
monocyte functions as they represent mature monocyte phenotypes and carry 
homogenous genetic behaviours (Qin, 2012). A number of studies have been carried out 
using THP-1 as a model such as in genetic study (Gillies et al., 2012) In addition, LPS-
stimulated THP-1 cells have been reported to activate and improve endothelial cell 
interactions similar to primary monocytes (Schildberger et al., 2013). The THP-1 gene 
expressions are also similar to peripheral blood mononuclear cells (PBMC)-derived 
macrophages (Sharif et al., 2007).  
 
U937 is a pro-monocyte cell line isolated from a 37-year-old Caucasian man with 
histiocytic lymphoma (Sundström and Nilsson, 1976). U937 also represents a human 
macrophage-like model (Liu et al., 2012) in several macrophage differentiation assays. 
U937 has been demonstrated to participate in the mechanism of monocyte-endothelium 
attachment and has been previously studied for biological effect of particles (Posada et 
al., 2015) as  well as cytokine release (Daigneault et al., 2010).   
 
Generally, U937 cells are stable as they can be used at a higher passage number compared 
to THP-1 which is stable only until passage 25 (Chanput et al., 2015) . In a long-term 
cryopreservation, U937 shows a stable recovery without any noticeable effect on 
monocyte features. THP-1 and U937 cells are commonly studied for their gene 
  
10 
 
transcription and cytokine production by using polymerase chain reaction (PCR), Western 
blot, ELISA and flow cytometry (Chanput et al., 2015). 
 
2.2  Microparticles  
Microparticles (MP), exosomes, and apoptotic bodies are extracellular vesicles released 
from cells (Théry et al., 2009). They can be distinguished based on different sizes, 
mechanism of vesicle formations as well as protein and lipid membrane contents (Table 
2.1). The sizes of apoptotic bodies and exosomes are approximately more than 1000 nm 
and 30–100 nm respectively. Apoptotic bodies are produced by cell death events while 
exosomes are formed by fusion of small fragment multivesicular bodies which are 
different from the profile of MP (Burger et al., 2013). 
 
Microparticles were first detected in 1967 and were known as platelet dust (Wolf, 1967). 
They are small membrane-bound particles of 0.1 to 1.0 µm in diameter (Wu et al., 2013). 
Under physiological conditions, MP are continuously released from their cells of origin 
during cellular apoptosis and following cellular activation by various stimuli. They are 
heterogeneous in size, composition, cellular origin and density (Zubairova et al., 2015). 
They carry antigens of their origin cells and transport them from the MP surface to other 
cells and organs (Mause and Weber, 2010).  
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Table 2.1 Characteristics of extracellular vesicles 
 
Exosomes Microparticles Apoptotic bodies 
Size 10-100 nm 100-1000 nm >10000nm 
Formation 
mechanism 
Fusion of 
multivesicular bodies 
with plasma 
membrane 
Outward blebbing 
of plasma 
membrane  
Late apoptosis 
Detection 
method 
Electron microscopy 
and Western blot 
Flow cytometry, 
capture-based assay 
and electron 
microscopy 
Flow cytometry, 
capture-based assay 
and electron 
microscopy 
Characteristic 
features 
LAMP1, CD63 and 
TSG101 
High PS expression 
and cell-specific 
surface markers 
High PS 
expression, DNA 
and permeable 
membrane 
Composition  Protein, RNA, 
miRNA 
Protein, RNA, 
miRNA 
Protein, DNA, cell 
organelles, RNA 
and miRNA 
Membrane 
properties 
Rich in lipid raft and 
impermeable 
Externalised 
phosphatidylserine, 
rich in lipid raft and 
impermeable 
Externalised 
phosphatidylserine 
and permeable 
Adapted from Burger et al., (2013). 
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Microparticles exist in circulating blood under normal conditions. However, under 
pathological conditions, MP levels are linked to disease severity. Microparticle levels are 
elevated in conditions associated with homeostasis, inflammation, cell survival and 
apoptosis, vascular remodelling, angiogenesis, endothelial function, infection, and 
immune-mediated diseases. Many studies have reported that MP contribute to 
pathological processes, thus MP may act as a potential biomarker and mediator of various 
diseases (Burnier et al., 2009; Roos et al., 2010; Zhang and Yang, 2012).  
 
The membrane compositions of MP reflect their membranous elements from their original 
cell. They convey genetic storage (e.g., microRNA, mRNA), cytoplasmic components 
such as adhesion molecules, membrane phospholipids, and specific antigens (Table 2.2) 
that arise from the cell of origin. The membrane compositions of MP also rely on the type 
of in vitro stimuli received from mother cells  (Nomura and Shimizu, 2015).  
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Table 2.2 List of antigens that are expressed on microparticles derived from erythrocytes, 
platelets, neutrophils, monocytes, lymphocytes and endothelial cells. 
Origin Cell  Antigens Stimuli on origin cell 
Erythrocytes CD35, CD235a (glycophorin A) A23187, pH, ATP depletion, 
decompression stress, 
diamide  
 
Endothelial 
cells 
CD31 (platelet endothelial cell 
adhesion molecules), CD144 
Shear stress, uremic toxins, 
CRP, Ang II, High Glucose, 
ROS, thrombin, IL-1α, TNF-α, 
LPS, PAI-1 
Platelets 
 
CD235a (glycophorin A) 
CD42a (GPIX) 
CD42b (GPIb) 
CD41 (GPIIb/IIIa, αIIb β3) 
CD61 (GPIIIa) 
CD62P (P-selectin) 
Shear stress, exercise, 
pregnancy, CD40L, ADP, 
thrombin, collagen, apoptosis, 
A23187, calcium, TRAP, PMA, 
Cytochalasin D, LPS, 
epinephrine 
Monocytes CD14 (endotoxin receptor) LPS, A23187, etoposide, TNF-
α, Fas ligand 
Lymphocytes CD4, CD8, CD20 Hepatitis C, storage, 
actinomycin D, PHA, 
etoposide, staurosporine, TNF-
α 
Neutrophils CD66b (CEACAM-1) 
CD51 (vitronectin receptor, αv 
β3) 
PMA, Bacterial infection, 
ANCA, FMLP 
Adapted from Nomura and Shimizu (2015). 
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2.2.1  Origin and structure of microparticles 
Microparticles  are derived from almost all eukaryotic cells such as erythrocytes, 
leukocytes, platelets, endothelial cells, tumour cells, and smooth muscle cells (Pliyev et 
al., 2014). Circulating MP from blood cells are the most reported in the literatures, in 
particular, platelet- and endothelial-derived MP (Amin et al., 2007; Burnier et al., 2009; 
Baron et al., 2012). One of the noticeable features of MP is the exposure of 
phosphatidylserine (PS) on their surface which can be detected by Annexin-V binding 
(Figure 2.2). 
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Figure 2.2 Structure and cellular composition of microparticle Various types of  
membrane proteins and receptors are exposed on a proposed microparticle structure as  
illustrated by Wu et al., (2013). Cytoplasmic contents within microparticles carry genetic  
materials from parent cells. 
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2.2.2  Formation and function of microparticles 
Microparticles are shed from their cell membrane by vesiculation and budding through 
physiological conditions such as cell activation, apoptosis or tissue damage. Their 
secretion can also be induced in vitro using stimulants such as LPS, TNF-α, calcium 
ionophore and histamine (Mastronardi et al., 2011; Neri et al., 2011; Bardelli et al., 2012). 
Phosphatidylserine  is a negatively-charged lipid membrane residue that arises from loss 
of membrane integrity due to calcium influx and cytoskeletal changes resulting from 
cellular apoptosis and activation (Owens and Mackman, 2011). The protrusion of PS on a 
lipid raft of a cell membrane is caused by the flip-flopping of lipid bilayer controlled by 
flippase, floppase, and scramblase enzymes. Phosphatidylserine externalisation is the 
result of cytoskeletal rearrangement and phospholipid membrane alteration events; 
however, the exact mechanism of PS exposure on plasma membrane is not precisely 
known. In addition, different experimental settings and cellular stimulations, for example, 
apoptosis stimulants (staurosporine), cellular stress inducers (ROS, serum deficiency, 
ultraviolet light), inflammatory cytokines (TNF-α) or transcription blockers (actinomycin 
D), will give rise to different expression level of PS and other surface markers (VanWijk 
et al., 2003; Wang et al., 2011; Baron et al., 2012).  
 
The level of MP is increased in many clinical settings such as in angiogenesis, thrombosis, 
haemostasis, and inflammation (Mack et al., 2000; Boulanger et al., 2001; Kim et al., 
2004). Microparticles may act as potential biomarkers in pathological conditions and 
provide early detection of inflammatory diseases which later aid possible therapeutic 
interventions (Burger et al., 2013). Furthermore, MP enhance cell-to-cell communication 
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for example, leukocyte microparticles (LMP) activate endothelial cells and transfer 
leukocyte antigens to epithelial cells while platelet microparticles (PMP) modulate 
monocyte-endothelial cell interactions and stimulate proliferation, survival, adhesion and 
chemotaxis of leukocytes. These demonstrate that MP can be an efficient vehicles of 
biological information from one cell type to another (Hugel et al., 2005). The function of 
MP is carried out by MP surface receptor and bioactive molecules including cytoplasmic 
contents such as cytokine, nucleic acids, and signal proteins. In addition, MP also play an 
important role in signal transduction by sensing bioactive molecules through surface 
receptors which later modulate cellular responses and contribute to innate and adaptive 
immunity (Hugel et al., 2005). Microparticles either stimulate or suppress immune 
response by secreting pro- or anti-inflammatory cytokines. (Distler et al., 2005b) 
 
2.2.3  Leukocytes-derived microparticles (LMP) 
Leukocytes-derived microparticles (LMP) are derived from white blood cells which 
include monocytes/macrophages, neutrophils, and B- and T-lymphocytes. Like other MP, 
they also carry surface markers and exhibit similar membrane and cytoplasmic proteins 
from their parent cells. Leukocyte-derived MP are mainly involved in either thrombosis 
or haemostasis depending on the presence of tissue factor (TF) and coagulation inhibitors. 
They also regulate inflammatory response by promoting the recruitment of immune cells 
and also modify endothelial cell functions (Angelillo-Scherrer, 2012) 
 
Neutrophil-derived microparticles (NMP) represent major LMP population as neutrophils 
make up 40% to 70% of the total circulating leukocytes in human blood. Neutrophils 
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originate from the bone marrow and have a short life span for approximately few hours. 
They play their function according to the target cells that they have to interact with. During 
inflammation, chemotactic signals trigger neutrophils to the infected area. 
Neutrophil-derived MP are released through exocytosis by activated neutrophils in the 
case of a bacterial infection or under in vitro stimulation using N-formyl-methionyl-
leucyl-phenylalanine (FMLP), anti-neutrophil cytoplasmic antibodies (ANCA), or PMA 
(Andrews and Berndt, 2008). Similar to other MP, NMP also expose PS on their outer 
membranes. Furthermore, they function as inflammatory mediators to activate the 
classical and complement pathways by interacting with endothelial cells and macrophages 
(Mesri and Altieri, 1999). Neutrophil-derived MP interact with resting platelets and assist 
in thrombin generation which later leads to thrombosis (Pluskota et al., 2008). 
 
Lymphocytes originate from hematopoietic stem cells in the bone marrow. Lymphoid 
progenitors migrate and mature in the thymus to become T-lymphocytes or remain in the 
bone marrow and differentiate into B-lymphocytes before entering peripheral blood. They 
represent 25% to 40% of leukocyte population. In autoimmune patients, the level of MP 
derived from B-lymphocytes (BMP) together with other LMP are elevated in the 
bloodstream (Baka et al., 2010). On the other hand, T-lymphocyte-derived microparticles 
(TMP) have broad functions such as activating nuclear factor-κB (NF-κB), upregulating 
cyclooxygenase-2 and nitric oxide expression, carrying Fas ligand and interacting with 
smooth muscle cells (Tesse et al., 2008; Carpintero et al., 2010).  
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Monocyte-derived microparticles (mMP) is another part of LMP and they are the main 
focus in this study. Monocytic MP arise from monocytes which constitute 5% to 10% of 
blood leukocytes. Monocytic MP have been reported to increase endothelial cell 
thrombogenicity by displaying many effector molecules such as TF, thrombomodulin 
(TM), activated protein C (APC), and tissue factor inhibitor (TFPI) on their surface 
(Aharon et al., 2008). Monocytic MP has also been shown to induce apoptosis by 
transferring caspase-1 as a cell death signal to smooth muscle cells (Sarkar et al., 2009). 
 
Generally, LMP take part in countless physiological processes including angiogenesis, 
atherosclerosis, endothelial function, inflammation, and thrombosis. Predicting LMP level 
might be useful as prognostic tools in cardiovascular events and they may exhibit their 
functional properties depending on the stimuli used for their in vitro generation and the 
type of cell origin (Angelillo-Scherrer, 2012). 
 
2.2.4  Isolation of microparticles 
Microparticle isolation involves several methods which depends on the original source of 
MP either from blood, tissues, body fluid, or cultured cells. Numerous studies have 
assessed MP generation in vitro compared to ex vivo due to the limited number of MP 
production from ex vivo blood (Baron et al., 2012). For MP isolation from blood samples, 
a proper selection of blood tube containing different anticoagulants play a major role in 
determining PS+ MP. For instance the use of blood collection tube with sodium citrate as 
anticoagulant results in significantly higher level of PS+ MP compared to blood collected 
in tubes containing heparin as an anticoagulant (Barteneva et al., 2013). However, due to 
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limited amount of MP generated ex vivo, many studies have used cells lines combined 
with in vitro culture technique in the presence of inflammatory or apoptotic stimuli to 
induce MP secretion in large quantities. As suggested by a previous study, all cell types 
can generate MP, however, each cell lines may display different response to apoptotic or 
inflammatory stimuli and thus differ in their ability to generate MP (Halim et al., 2016). 
The most often used cell lines are human umbilical vein endothelial cells (HUVEC) and 
human lymphoid cells which is Jurkat cells (Baron et al., 2012).  
 
Many studies have used differential centrifugation technique to isolate MP from the whole 
blood or stimulated cell lines as described in the literatures (Dey-Hazra et al., 2010; 
Barteneva et al., 2013; Wen et al., 2014; Crompot et al., 2015). Briefly, a cell-free 
supernatant is first prepared through centrifugation at 1,500 ×g before being centrifuged 
at a high speed (~20,000 ×g) to pellet MP (Baron et al., 2012). However, it should be 
considered that filtration and washing steps of MP pellet after the final ultracentrifugation 
are not recommended as it may reduce the number of events, particularly during flow 
cytometry analysis. The washing steps and filtration can lead to fragmentation of larger 
MP (Barteneva et al., 2013; Nielsen et al., 2014). Furthermore, the buffers involved during 
centrifugation of MP should be filtered and the samples should be analysed either fresh or 
stored in the same duration as the storage condition of MP. These steps are essential to 
ensure reproducible MP and minimise the chances of phenotypic modification of MP 
(Dey-Hazra et al., 2010).  
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2.2.5  Detection of microparticles 
Various methods to identify MP populations and to characterise their phenotypic and 
proteomic profiles have been reported in the literatures (Table 2.2). These methods include 
electron microscopy, mass-spectrometry, flow cytometry, and functional assays such as 
clotting test, enzyme-linked immunosorbent assay (ELISA) as well as light scattering 
techniques like nanoparticle tracking analysis, dynamic light scattering, and submicron 
particle analysis. Although a standard measurement procedure of MP characterisation has 
not been established yet, flow cytometry and microscopy techniques are the most reliable 
and preferred methods to quantitatively measure MP (Barteneva et al., 2013). 
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Table 2.3 List of microparticle detection methods 
Assays Methods   Limitations 
Electron microscopy Observe MP morphology 
including diameter and cross 
section 
May include artefact 
detection produced from 
sample preparation 
Functional assays 
(ELISA, procoagulant 
activity, thrombin 
generation) 
Identify coagulation and 
prothrombinase of MP 
Only a single parameter 
of biological function is 
measured each time 
Immunoassays Capture MP based on presence of 
surface antigen 
Quantification of bulk 
rather than individual MP 
Mass spectrometry Identify multiple protein content 
in MP 
Unable to estimate MP 
size and involve many 
starting materials 
Light scattering 
techniques (dynamic 
light scattering, 
nanoparticle tracking 
analysis [NTA]) 
Clearly visualise MP by size light 
microscopy and light scattering 
involving Brownian motion of 
single MP 
Time consuming 
Non-universal 
technology 
Atomic force 
microscopy 
Using cantilever to examine MP 
surface 
Non-universal 
technology 
Adapted from Barteneva et al., (2013) and Burger et al., (2013).  
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2.2.5 (a)  Flow cytometry analysis 
Flow cytometry is the most widely used technique to identify MP due to its feasible and 
broad parameters as well as the ability to rapidly enumerate individual MP in many 
samples (Poncelet et al., 2015). Acquisition in flow cytometry analysis is based on the 
light scattering and fluorescent intensity produced when a single particle in a suspension 
form travels through a fluid stream and then recorded by a specialised software (Adan et 
al., 2017). Theoretically, it quantifies antigens expressed on cell surface by using 
antibodies that are covalently attached to fluorescent markers. Monoclonal antibodies 
(mAb) are typically used as they have high specificity and specific epitope for a particular 
antigen (Lydyard et al., 2011). 
 
Besides measuring surface markers, size-calibration beads can also be used to determine 
the heterogeneity of MP size (Aass et al., 2011; Crompot et al., 2015). The beads have 
different sizes, ranging from 300 to 1000 nm in diameter, and are assessed by the forward 
scatter parameter on a flow cytometry. Size-calibration fluorescent technique is normally 
performed to identify MP gate on a dot plot as a preliminary standardisation template. 
However, the drawback of using polystyrene synthetic beads is that they give a higher 
signal due to refractive index and may lead to false estimation of MP size (Nomura et al., 
2002; Nielsen et al., 2014; Crompot et al., 2015). 
 
Several studies have suggested a few technical strategies for MP detection. Firstly, an 
absolute minimum threshold of 200 at the side scatter (SSC-A) parameter is preferred for 
MP population to avoid the exclusion of smallest events and minimise the distribution of 
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instrumental noises (Aass et al., 2011). Secondly, the detection of particle size is set up 
below 1.0 µm by using size-fluorescent bead and supported with double positive staining 
of surface marker and PS marker (if applicable) to separate true events from background 
noises (Aass et al., 2011). Moreover, filtration of staining buffer with 0.22 µm filter 
membrane and using a low flow rate may be able to distinguish particles from background 
debris (Ogata et al., 2006; Neri et al., 2011; Hoyer et al., 2012; Nielsen et al., 2014; Walsh 
et al., 2017).  
  
